| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +38% |
| 3Y CAGR | +17% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +174% |
| 3Y CAGR | +17% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,362.80 +10.40 (0.44%) | 17,958.14 | 26.49 | 5.33 | ||
PfizerPFIZER | ₹3,734.40 +24.60 (0.66%) | 17,040.57 | 23.18 | 4.05 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,237.00 +164.00 (2.70%) | 15,586.75 | 91.89 | 17.86 | ||
Natco PharmaNATCOPHARM | ₹793.00 -1.55 (0.20%) | 15,562.98 | 13.6 | 1.48 |